Dong Qing Dan Shen Pian (Dong Qing Dan Shen Wan,
冬青丹参丸),
literally "Ilex & Salvia Tablets" in Chinese,
is a Chinese herbal medicine specially formulated to support a healthy
heart function.† The Chinese medicine may help promote blood flow in
the heart and manage angina in people who are at risk of coronary artery disease and
heart attack.†
|
|
What does it do?
Coronary artery disease or coronary heart disease is the narrowing of the wall of the coronary arteries that supply
the muscles of the heart with oxygen and nutrients. The resulting limitation of blood flow
to the heart may cause lack of oxygen and nutrients in the heart and may be felt as oppressed
sensation in the heart and chest and chest pain (angina pectoris). In severe conditions
myocardial cells may die and cause heart attack. Coronary artery disease is developed as a result of
inflammation of cells in the inner lining of coronary arteries in a process called atherosclerosis that
fills the wall with the plagues.
Dong Qing Dan Shen Pian consists of a unique array of Chinese herbs that are known in traditional Chinese
medicine to activate blood, remove blood stasis, and nourish the heart. The Chinese medicine
is our signature formula for the care of coronary artery disease.
• Mao Dong Qing (Ilex Pubescens root) is the chief Chinese herb in the formula with
the property of activating blood and cleaning the vessels. In
China its preparations are often used in clinics to treat coronary artery disease and angina with
satisfying results.† In various studies most patients were observed with significant improvement
in symptoms like chest pain and dizziness after intake of Ilex preparations for one month. No severe side
effect was noticed. In animal models, it has been found that Ilex extracts may expand or dilate
the coronary arteries to increase the blood flow. The effect is slower to onset but lasts longer than
nitroglycerin. Moreover, components isolated from Ilex Pubescens are found to have anti-platelet
aggregation1 and anti-inflammation2 activities. Thus, the Chinese herb may
act both at increasing blood flow and reducing atherosclerosis to be beneficial to heart health.
• Dan Shen (Salvia root) is another chief Chinese herb in the formula. Dan Shen
is very known and perhaps the most commonly used in Chinese medicine for promoting blood circulation and removing
blood stasis.† A Dan Shen preparation was approved by FDA for clinical trials in USA.
|
What is the formula composition?
A proprietary blend* of
Radix Ilex Pubescens
Radix Salviae Multiorrhizae
Lignum Santali Albi
Rhizoma Chuanxiong
Flos Carthami
Radix Curcumae
Radix Bupleuri
Radix Notoginseng
|
(Mao Dong Qing)
(Dan Shen)
(Tan Xiang)
(Chuan Xiong)
(Hong Hua)
(Guang Yu Jin)
(Chai Hu)
(Jing Tian San Qi)
|
| This formula list may appear differently
from the label of the product you receive. learn more
|
|
*Dong Qing Dan Shen Wan (Pian) is made of 100% pure authentic Chinese
herbs of highest qualities.
Traditional preparation procedures are combined with modern pharmaceutical processes to extract the active
ingredients from the herbs and to further concentrate them into pills or tablets. It is produced in the certified
GMP facilities of Shanghai TongHanChun Herbs Factory (Guang Ci Tang) and is imported to USA in accordance with the FDA guidelines.
|
What is Available?
40 grams in 200 mg 200 tablets (pian) or 200 mg 200 pills (wan).
|
How do I use it?
Take 5 to 7 tablets or pills 2-3 times daily.
|
Use Discretion
|
Side Effects
Dong Qing Dan Shen Wan (Pian) has been safely used with few adverse effects when used as directed.
|
Cautious Notes
1. Do not use it during pregnancy.
2. Consult your herbalist or physician before use if you are taking other medicines.
3. Keep out of reach of children.
|
References
1. Jiang Z-H. et al., Hemiterpene Glucosides with Anti-Platelet Aggregation Activities from Ilex pubescens
J. Nat. Prod., 2005, 68 (3), pp 397–399.
2. Wang JR et al., In vivo anti-inflammatory and analgesic activities of a purified saponin fraction derived from the root of Ilex pubescens.
Biol Pharm Bull. 2008 Apr;31(4):643-50.
|
